MedPath

NeuRA Launches World's Largest Clinical Trial for Phantom Limb Pain

  • Neuroscience Research Australia (NeuRA) has initiated TITAN, a large-scale clinical trial, to evaluate potential treatments for phantom limb pain.
  • The trial will assess two drug-free interventions: a progressive rehabilitation program using mirror therapy and low-frequency non-invasive neuromodulation.
  • Phantom limb pain affects up to 80% of individuals post-amputation, causing severe symptoms and significantly impacting quality of life.
  • The Australia-wide trial, conducted online by physiotherapists, seeks participants experiencing phantom limb pain to join the study.
Neuroscience Research Australia (NeuRA) has commenced the TITAN clinical trial, the world's largest study to date investigating potential treatments for phantom limb pain. This initiative aims to address a condition that affects a significant proportion of individuals who have undergone limb amputation or experienced spinal cord injuries.

Addressing Phantom Limb Pain

Phantom limb pain is characterized by sensations felt in a body part that is no longer present, often manifesting as intense burning, shooting, or electric shock-like pain. These sensations can severely disrupt sleep, lead to depression, and diminish overall quality of life. According to NeuRA Senior Research Scientist Professor James McAuley, current treatments often provide limited relief and are accompanied by significant side effects, highlighting the urgent need for more effective interventions.

Investigating Drug-Free Treatments

The TITAN trial will evaluate two drug-free treatments designed to modify how the brain processes pain signals. The first intervention involves a progressive rehabilitation program incorporating techniques like mirror therapy. The second utilizes low-frequency non-invasive neuromodulation. Both approaches aim to reduce pain and improve function without the adverse effects associated with traditional analgesic medications.

Trial Design and Accessibility

This randomized clinical trial, funded by the Commonwealth Government, will be conducted online by physiotherapists, ensuring broad accessibility across Australia. Researchers are actively recruiting participants who experience phantom limb pain to join the study and contribute to the advancement of pain management strategies.

The Impact of Phantom Limb Pain

Phantom limb pain can lead to social isolation and a loss of independence. The condition's debilitating symptoms often persist for a lifetime, underscoring the importance of finding treatments that can provide meaningful and lasting relief. NeuRA's TITAN trial represents a significant step forward in the pursuit of effective solutions for this challenging condition.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Reference News

[1]
NeuRA launches world's largest clinical trial for phantom limb pain - News Hub
newshub.medianet.com.au · Aug 29, 2024

NeuRA is conducting TITAN, the world's largest clinical trial for phantom limb pain, investigating two drug-free treatme...

© Copyright 2025. All Rights Reserved by MedPath